‘Baraclude’ won the lawsuit of injunction in patent infringement against Dong-A

BMS Pharmaceutical Korea(President Hye-sun Park) announced on the 7^th the company has won a lawsuit of injunction in patent infringement against Dong-A ST over ‘Baraclude® (generic name: entecavir),’ a chronic hepatitis B treatment.

According to BMS Pharmaceutical Korea, although there was a judgment of the Intellectual Property Tribunal and a ruling of the Patent Court that the substance pate...